BioSpace News Archive

DNA Diet Plan, a first-of-its-kind, personalized, and scientifically-grounded online weight loss program, is now available.

VenatoRx Pharmaceuticals announced that its President and CEO, Christopher J. Burns, Ph.D., will present during the First Time Disclosure of Clinical Candidates at the American Chemical Society (ACS) National Meeting.

Monarch Medical Technologies, the leader in precision insulin dosing technology for optimized glycemic management, today announced that Bruce Lisanti has been named president and chief executive officer, effective immediately.

CIRCULOGENE, advancing precision medicine through personalized molecular genetics testing, will be presenting three abstracts at the 2019 American Association for Cancer Research (AACR) Annual Meeting, March 29 - April 3, 2019, at the Georgia World Congress Center in Atlanta.

Riverside Partners, a Boston-based private equity firm, is introducing Revecore, a company bringing together best-in-class organizations to deliver specialized services in the most challenging areas of hospital revenue cycle management.

It may be possible to lower the high risk of preterm birth among African American women with certain immune and bacterial factors in the microbiome of the cervix and vagina that appear to modulate this risk, according to new research published in Nature Communications.

Teachers can engage their students in one of the hottest topics in science with Understanding Climate Change, Grades 7–12.

Recent nerve-gas attacks on civilians suggest the need for better preparedness, writes Steven Hatfill. M.D., in the spring issue of in the Journal of American Physicians and Surgeons.

As our population ages, the burden of dementia patients grows inexorably. Since 2003, no new anti-dementia drugs have been approved, and numerous phase III drug trials have failed.

The American Journal of Managed Care® (AJMC®), the leading peer-reviewed journal dedicated to issues in managed care, with its Institute for Value-Based Medicine® will host a regional VB-Onc™ meeting that will provide an overview of the future of the Oncology Care Model (OCM) and advancing alternative payment models in oncology.